Niki BioSolutions, Inc. (NIKI) Short-term Investments (2017 - 2023)

Niki BioSolutions (NIKI) has 7 years of Short-term Investments data on file, last reported at $102109.0 in Q4 2023.

• Quarterly Short-term Investments fell 96.74% year-over-year to $102109.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $102109.0 (down 96.74% YoY) and the FY2024 annual result came in at $4206.0, down 95.88% from the prior year.
• Short-term Investments eased to $102109.0 in Q4 2023, from $3.1 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $28.4 million in Q4 2020 to a low of $102109.0 in Q4 2023.
• A 5-year average of $4.0 million and a median of $702937.0 in 2021 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2020 — Short-term Investments jumped 2569.99% — and 2021, when it tumbled 99.54%.
• Tracing NIKI's Short-term Investments over 5 years: stood at $1.1 million in 2019, then jumped by 2569.99% to $28.4 million in 2020, then plunged by 99.54% to $130270.0 in 2021, then surged by 2302.96% to $3.1 million in 2022, then plunged by 96.74% to $102109.0 in 2023.
• The last three Short-term Investments figures came in at $102109.0 (Q4 2023), $3.1 million (Q4 2022), and $153905.0 (Q2 2022), per Business Quant data.